Cargando…
N-Terminal Fatty Acids of NEF(MUT) Are Required for the CD8(+) T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
We recently described a cytotoxic CD8(+) T lymphocyte (CTL) vaccine platform based on the intramuscular (i.m.) injection of DNA eukaryotic vectors expressing antigens of interest fused at the C-terminus of HIV-1 Nef(mut), i.e., a functionally defective mutant that is incorporated at quite high level...
Autores principales: | Chiozzini, Chiara, Manfredi, Francesco, Arenaccio, Claudia, Ferrantelli, Flavia, Leone, Patrizia, Federico, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350016/ https://www.ncbi.nlm.nih.gov/pubmed/32456079 http://dx.doi.org/10.3390/vaccines8020243 |
Ejemplares similares
-
The C-Terminal Domain of Nef(mut) Is Dispensable for the CD8(+) T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2021) -
Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
por: Ferrantelli, Flavia, et al.
Publicado: (2020) -
Long-Term Antitumor CD8(+) T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
por: Ferrantelli, Flavia, et al.
Publicado: (2021) -
Simultaneous CD8(+) T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
por: Ferrantelli, Flavia, et al.
Publicado: (2021) -
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
por: Manfredi, Francesco, et al.
Publicado: (2022)